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Abstract: More than two billion people (one-third of
humanity) are infected with parasitic roundworms or
flatworms, collectively known as helminth parasites. These
infections cause diseases that are responsible for enor-
mous levels of morbidity and mortality, delays in the
physical development of children, loss of productivity
among the workforce, and maintenance of poverty.
Genomes of the major helminth species that affect
humans, and many others of agricultural and veterinary
significance, are now the subject of intensive genome
sequencing and annotation. Draft genome sequences of
the filarial worm Brugia malayi and two of the human
schistosomes, Schistosoma japonicum and S. mansoni, are
now available, among others. These genome data will
provide the basis for a comprehensive understanding of
the molecular mechanisms involved in helminth nutrition
and metabolism, host-dependent development and
maturation, immune evasion, and evolution. They are
likely also to predict new potential vaccine candidates and
drug targets. In this review, we present an overview of
these efforts and emphasize the potential impact and
importance of these new findings.
Helminth Infections—The Great Neglected
Tropical Diseases
Helminth parasites are parasitic worms from the phyla
Nematoda (roundworms) and Platyhelminthes (flatworms)
(Figures 1 and 2); together, they comprise the most common
infectious agents of humans in developing countries. The collective
burden of the common helminth diseases—which range from the
dramatic sequelae of elephantiasis and blindness to the more
subtle but widespread effects on child development, pregnancy,
and productivity—rivals that of the main high-mortality condi-
tions such as HIV/AIDS or malaria [1]. For example, based on a
recent analysis [2], 85% of the neglected tropical disease (NTD)
burden for the poorest 500 million people living in sub-Saharan
Africa (SSA) results from helminth infections. Hookworm infection
occurs in almost half of the poorest people in SSA, including 40–
50 million school-aged children and 7 million pregnant women, in
whom it is a leading cause of anemia. Schistosomiasis (192 million
cases) is the second most prevalent NTD after hookworm,
accounting for 93% of the world’s number of cases of
schistosomiasis and possibly associated with increased horizontal
transmission of HIV/AIDS. Lymphatic filariasis (46–51 million
cases) and onchocerciasis (37 million cases) are also widespread in
SSA, each disease representing a significant cause of disability and
reduction in the region’s agricultural productivity. The disease
burden estimate in disability-adjusted life years (DALYs) for total
helminth infections in SSA is 5.4–18.3 million in comparison to
40.9 million DALYs for malaria and 9.3 million DALYs for
tuberculosis. Yet, research into helminth infections has not
received nearly the same level of support. This is partly because
helminthiases are diseases of the poorest people in the poorest
regions, but also because these pathogens are difficult to study in
the laboratory by comparison to most model eukaryotes and many
other pathogens. Standard tools and approaches, including cell
lines, culture in vitro, and animal models, are generally lacking. In
addition, the genomes of helminths are generally much more
complex than those of model organisms like yeast and fruit flies
[2].
Whereas helminth diseases are ancient scourges of humanity,
with some known from biblical times, most can also be considered
as re-emerging diseases in the sense that new outbreaks are
reported routinely in response to environmental and sociopolitical
changes [3]. For example, schistosomiasis has reemerged many
times in Africa in recent times in response to hydrological changes,
e.g. construction of dams, irrigation canals, reservoirs, etc. that
establish suitable new environments for the intermediate host
snails that transmit the parasites. Schistosomiasis has also
reemerged in mountainous and hilly regions in Sichuan, China,
where it had been controlled previously by intensive interventions
[4]. Furthermore, new strains of schistosomes are indeed emerging
through natural hybridizations between human and cattle species
of schistosomes [5].
Despite the difficulties with investigation of helminth parasites,
new insights into fundamental helminth biology are accumulating
through genome projects and the application of genome
manipulation technologies including RNA interference and
transgenesis (Figure 3). What’s more, research on immunology
of helminth infections has contributed enormously to our
understanding of Th2 immune responses, the function of
regulatory T cells, generation of alternatively activated macro-
phages, and the transmission dynamics of infectious agents. It is
hoped that this progress can be translated into new and robust
drugs, diagnostics, and vaccines for the helminth diseases
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of humanity and those of our livestock and companion species
[1,6–10].
Genomics Approaches to Investigating Helminths
Over the past decade, increasing numbers of helminth-specific
genome sequences have become available due to ever-improving
techniques for obtaining biological material, extracting RNA and
DNA, constructing complimentary DNA (cDNA)/whole genome
shotgun libraries, and, especially, major advances in the chemistry
and instrumentation for DNA sequencing and its concomitant
decreased cost. Helminth genomics began with the generation and
analysis of transcribed sequences (expressed sequence tags [ESTs]
[11]), which has proved to be a rapid and cost-effective route to
discover genes in other eukaryotes. In April 2009, there were
,550,000 nematode and 450,000 platyhelminth ESTs in the
dbEST division of GenBank, excluding those from the model
nematode Caenorhabditis rhabditis. Of these, 60% were from
parasites of humans and closely related animal pathogens used
to study human infections (Table 1). These ESTs have many
applications. They can be used to annotate helminth genomes (see
below) to determine alternative splicing, verify open reading
frames, and confirm exon/intron and gene boundaries. They are
valuable also, for example, in functional genomics to design probes
for expression microarrays (e.g., [12]) and to provide putative
protein sequence information for proteomics methods (e.g., [13]),
to name but a few applications. Quantitative analysis of ESTs
(transcriptomics), including serial expression of gene analysis, can
identify transcripts that are either over- or under-represented by
comparison to other transcripts in various helminth life cycle
stages or tissues (e.g., [14,15]), and the subset of genes evaluated
with gene ontology programs provide insights into cellular and
metabolic pathway functioning in the parasite (e.g., [16]).
Furthermore, one can identify potential targets for interventions
by applying a hierarchy of considerations including a matrix of
biological, expression, and phenotypic data [17] or by performing
a pan-phylum analysis to identify conserved parasite-specific genes
whose selective targeting will have low or no toxicity to the host
[18,19] or genes that have diverged enough from the host
counterpart, resulting in altered or absent functions [20].
The first multicellular genome sequenced was that of the free-
living roundworm C. elegans [21]; reported in 1998, it is still the
only metazoan for which the sequence of every nucleotide is
known with high confidence. Today, the genome sequences of 22
species of helminths that either infect humans or are closely related
parasites are completed or underway (Table 1). A comprehensive
genome analysis has been published for several of them, including
the lymphatic filarial nematode Brugia malayi [22], the dog
hookworm Ancylostoma caninum [23], and the blood flukes
Schistosoma japonicum and S. mansoni [24,25] (Figure 1; Table 1).
Figure 1. Montage of some of the major human helminth parasites, their developmental stages, and disease pathology. (A)
Microfilaria of Brugia malayi in a thick blood smear, stained with Giemsa (http://www.dpd.cdc.gov/dpdx/html/frames/a-f/filariasis/body_
Filariasis_mic1.htm); the microfilaria is about 250 mm in length. (B) Patient with lymphedema of the left leg due to lymphatic filariasis (http://
www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/index.htm). (C) Hookworm egg passed in the stool of an infected person; the microscopic egg,
barrel-shaped with a thin wall, is about 70640 mm in dimension. (D) longitudinal section through an adult hookworm attached to wall of small
intestine, ingesting host blood and mucosal wall. The parasite is about 1 cm in length. (E) Eggs of Schistosoma mansoni. The egg is about 150650 mm
in dimension; the lateral spine is diagnostic for S. mansoni in comparison to the other human schistosome species. Fibrotic responses to schistosome
eggs trapped in the intestines, liver, and other organs of the infected person are the cause of the schistosomiasis pathology and morbidity. (F) A pair
of adult worms of the blood fluke Schistosoma mansoni; the more slender female worm resides in the gynecophoral canal of the thicker male. The
worms are about 1.5 cm in length, and live for many years (http://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Schistosomiasis_il.htm ).
doi:10.1371/journal.pntd.0000538.g001
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Some of the main obstacles to research on human parasites are
their life cycle complexity, tissue complexity, and the paucity of
genetic and transgenic methods for manipulating genes of interest.
Comparative genome analyses have also provided insights into the
adaptations of various parasites to niches in their human (and
vector) hosts as well as insights into the molecular basis of the
mutualistic relationship between the filarial nematode B. malayi
and its endosymbiont Wolbachia (see below).
The genomes of the schistosomes S. japonicum and S. mansoni are
the first complete genomes reported for members of the
Lophotrochozoa [24,25], a large taxon that includes about 50%
of all metazoan phyla including the mollusks, annelids, brachio-
pods, nemerteans, bryozoans, playthelminths, and others [26].
These schistosome genome sequences revealed remarkable
features of the host–parasite relationship. Among these, the
schistosome genome has lost numerous protein-encoding domains.
Whereas the total number (,6,000) of protein families is broadly
similar among schistosomes, humans, C. elegans, and fruit fly, about
1,000 protein domains have been abandoned by S. japonicum,
including some involved in basic metabolic pathways and defense,
implying that loss of these domains could be a consequence of the
adoption of a parasitic way of life. If so, the remaining molecular
repertoire must have evolved in parallel with this extensive domain
loss to permit the pathogen to locate and infect humans efficiently,
nourish itself, and interact with the external environment as well as
with the host. On the other hand, despite extensive gene and
domain loss, a number of schistosome gene families have
expanded and these provide insights into the requirements for a
parasitic lifestyle. Among the expanded gene families, a metallo-
protease called invadolysin (or leishmanolysin) has at least 12
putative family members in schistosomes compared to a single
orthologue in the human, fruit fly, and C. elegans genomes and only
three in the free-living flatworm S. mediterranea. This protease
family may facilitate skin penetration and tissue invasion by the
cercaria, the infective-stage larva of the schistosome [24,25].
Publication of genome sequences of filaria and schistosomes has
underscored the pressing need to develop functional genomics
approaches for these significant pathogens. Functional analyses—
which use approaches such as RNA interference (RNAi) and
translational studies—are essential to resolve uncertainties in the
molecular physiology of helminths and to illuminate mechanisms
of pathogenesis that may lead to development of new interventions
to control and eliminate these parasites or the diseases. Progress in
the functional genomics of helminths was reviewed recently
[6,27,28]. In brief, RNAi has been used to inactivate the RNA
products of several genes in schistosomes (e.g., [29–32]) and
nematodes (e.g., [33]; reviewed in [8]). In addition, the recent
genome sequences of S. mansoni and S. japonicum now make feasible
genome-scale investigation of transgene integration into schisto-
some chromosomes. Gene therapy–like approaches to transform
schistosomes include the use of the piggyBac transposon and
pseudotyped murine leukemia retrovirus as transgene vectors
Figure 2. Phylogeny of the major taxa of human helminths—nematodes and platyhelminths—as established by maximum
likelihood (ML) analysis of 18S ribosomal RNA from 18 helminth species. Sequences were aligned using ClustalX [93]. The topology of the
tree was derived from a consensus tree by neighbor-joining–based bootstrapping, its branch lengths were computed using a ML-based method, and
it was rooted with the orthologue from the brewer’s yeast, Saccharomyces cerevisiae. The branch lengths of the phylogenetic tree were computed
using DNAML (PHYLIP package [94]) by allowing rate variation among sites. The headings Chromadorea, Enoplea, Trematoda, and Cestoda are major
classes of the phyla Nematoda and Platyhelminthes. The GenBank accession numbers of aligned sequences are DQ118536.1 (Trichuris trichiura),
AY851265.1 (Trichuris suis), AF036637.1 (Trichuris muris), AY497012.1 (Trichinella spiralis), U94366.1 (Ascaris lumbricoides), AF036587.1 (Ascaris suum),
AF036588.1 (Brugia malayi), AJ920348.1 (Necator americanus), AJ920347.2 (Ancylostoma caninum), AF036597.1 (Nippostrongylus brasiliensis), X03680.1
(Caenorhabditis elegans), AF036605.1 (Strongyloides ratti), U81581.1 (Strongyloides ratti), AB453329.1 (Strongyloides ratti), AF279916.2 (Strongyloides
stercoralis), AB453315.1 (Strongyloides stercoralis), M84229.1 (Strongyloides stercoralis), EU011664.1 (Saccharomyces cerevisiae), , U27015.1
(Saccharomyces cerevisiae), DQ157224.1 (Taenia solium), AF229852.1 (Clonorchis sinensis), Z11590.1 (Schistosoma japonicum), Z11976.1 (Schistosoma
haematobium), U65657.1 (Schistosoma mansoni).
doi:10.1371/journal.pntd.0000538.g002
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[34–36] (Figure 3A), both of which offer a means to establish
transgenic lines of schistosomes, to elucidate schistosome gene
function and expression, and to advance functional genomics
approaches for these parasites. Notably, progress is also being
made to express reporter transgenes in parasitic nematodes
including Strongyloides stercoralis [37], in which transgene approaches
developed for use in C. elegans have recently been used to
demonstrate that morphogenesis of infective larvae requires the
DAF-16 orthologue FKTF-1 (Figure 3B) [38]. Progress is also
being made with systems for analysis of promoter sequences of
genes of parasitic nematodes (e.g., [39]).
Many future discoveries resulting from the parasitic helminths
genome information can be expected to emanate from the broader
scientific community rather than by the laboratory originating a
genome sequence project. For the specialized genome sequence
labs, dissemination of sequence information in a way that is useful,
consistent, centralized, and lasting has been therefore a key goal.
Efforts have gone well beyond depositing raw data in public
databases. Currently, helminthologists have available a number of
specialized sites for sequence analysis. C. elegans information is
easily accessible at http://www.wormbase.org [40]. Useful
information about the organism includes genome sequence,
genetic and physical maps, transcript data (EST, mRNA, SAGE,
TEC-RED, ORFeome, expression patterns from reporter gene
fusions, and microarrays), the developmental lineage of all cells,
connectivity of the nervous system, mutant phenotypes and genetic
markers, gene expression described at the level of single cells, 3D
protein structures, NCBI Clusters of Orthologous Groups, and
apoptosis and aging information. It also contains extensive
information from large-scale genomics analyses, including pre-
computed sequence similarity searches, protein motif analyses,
protein–protein interactions, findings from systematic RNAi
screens, single nucleotide polymorphisms (SNPs), orthologous
and paralogous relationships, and the assignment of Gene
Ontology (GO) terms to gene products. These resources greatly
aid in the interpretation of much of the sequence data emerging
from parasitic helminths.
However, accumulating evidence suggest that C. elegans is not a
good model for all parasitic helminths, especially for the ones that
are phylogenetically very distant such as the basic nematode and
zoonotic parasite Trichinella spiralis (e.g., [41]). The other
specialized site is Nematode.net (http://www.nematode.net)
[42]), developed with a primary aim to disseminate the diverse
collection of information for parasitic nematodes to the broader
scientific community in a way that is useful, consistent, centralized,
and enduring. In addition to sequence data, the site hosts
assembled NemaGene clusters in GBrowse views, characterizing
composition and protein homology, functional Gene Ontology
annotations presented via the AmiGO browser, KEGG-based
graphical display of NemaGene clusters mapped to metabolic
pathways, codon usage tables, NemFam protein families (which
represent conserved nematode-restricted coding sequences not
found in public protein databases), and a Web-based WU-BLAST
search tool that allows complex querying and other assorted
resources. Furthermore, Nematode.net, by connecting data across
the entire phylum Nematoda, has made a substantial contribution
toward integrating the historically separate fields of C. elegans,
vertebrate parasitology, and plant parasitology research. Finally,
Figure 3. Some recent approaches to expressing transgenes in human helminths. (A) Luciferase activity in Schistosoma mansoni larvae
(schistosomules) after transduction with a pseudotyped retrovirus that expresses the luciferase reporter gene. Anti-luciferase antibody staining of
schistosomules three days after exposure to pseudotyped lentivirus carrying the firefly luciferase transgene. Schistosomules examined by confocal
laser microscopy; (i) bright field, (ii) fluorescence red channel, (iii) merged images. Control non-transformed worms showed only background levels of
fluorescence (not shown; see [34–36] for relevant hypotheses and experimental methods). (B) Recent studies on transgenic Strongyloides stercoralis
indicated that morphogenesis of the infective L3 stage larva requires the DAF-16 orthologue FKTF-1 [38]. L3s of this parasitic nematode were
transfected with plasmids carrying the transgene fktf-1b::gfp::fktf-1b and examined by fluorescence microscopy. (i, ii) Transgenic first-stage larvae
express green fluorescent protein (GFP) in the procorpus (arrow) of the pharynx. (iii, iv) A first-stage larva (L1) expresses the GFP::FKTF-1b(wt)
transgene in the hypodermis. (v, vi) An infective L3 expresses the GFP::FKTF-1b(wt) fusion protein in the hypodermis and in a narrow band in the
pharynx (arrow). Scale bars, 10 mm. Adapted from [38].
doi:10.1371/journal.pntd.0000538.g003
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Nembase (http://www.nematodes.org [43]) also offers access to
parasite sequence and tools such as visualization of clusters by
stage of expression.
While each of these databases has been challenged by the
requirement to support the influx of new genomes and related
data, they nonetheless provide user communities with innovative
features and tools suited to their needs that are beyond the scope of
the large sequence repositories. For flatworms (Figure 2), it is
notable that public genome annotation and analysis tools are
already in place, including SchistoDB (http://schistoDB.net/), a
genomic database for S. mansoni that incorporates sequences and
annotation [44] and SjTPdb, http://function.chgc.sh.cn/sj-
proteome/index.htm, an integrated transcriptome and proteome
database and analysis platform for S. japonicum [45]. The genome
database for the planarian Schmidtea mediterranea, a model free-living
platyhelminth, can be expected to be advantageous to comparative
genome projects and specific research problems for the growing
number of parasitic flatworms that now are or will be subjects of
genome sequence analysis. In addition, because of the phyloge-
netic position of planarians as early bilaterian metazoans,
SmedGD (http://smedgd.neuro.utah.edu) will prove useful not
only to planarian research, but also to investigations on
developmental and evolutionary biology, comparative genomics
(specifically with parasitic flatworms including flukes and tape-
worms), stem cell research, and regeneration [46]).
Evolution of Parasitism in Helminths
Genomics research has helped our understanding of the
evolution of helminths of humans and other hosts, certainly with
regard to roundworms of the phylum Nematoda. The first
comprehensive study of the molecular evolution of helminths
was a phylogenetic analysis of the small subunit ribosomal DNA (ss
rDNA) sequences from 53 roundworms [47]. This study included
both major parasitic and free-living taxonomic groups. It identified
five major clades within the Nematoda and suggested that
parasitism of animal and plants arose independently multiple
times. A more recent study included 339 nearly full-length ss
rDNAs and proposed subdivision of the phylum into 12 clades
[48]. This revealed that nematodes that feed on fungi occupy a
basal position compared to their plant parasite relatives,
confirming that the parasitic nematodes of plants arose from
fungivorous ancestors. Phylogenetic methods are also being used
to study evolution of parasitism-related protein-coding genes (such
as the enzymes that degrade the plant cell wall in nematode
parasites of plants [cellulases, pectate lyases, etc.]) to understand
better the mechanisms underlying the evolution of parasitism
(reviewed in [49]). Recent genome-wide analysis of two plant
parasitic nematodes [50,51] provided a more complete picture of
the acquisition of these cellulase genes, apparently by horizontal
gene transfer (HGT) from prokaryotes. The subsequent expansion
and diversification of HGT genes in these nematodes allow
inferences about the evolutionary history of these parasites, and in
addition present potential targets for anti-nematode drugs. When
the genome of the necromenic nematode Pristionchus pacificus was
reported recently, it became was clear that cellulases were not
restricted to plant parasitic nematodes; their presence in this
species indicated preadaptation for parasitism of animals [52],
consistent with the intermediate evolutionary position of Pris-
tionchus between the microbivorous C. elegans and the animal
parasitic nematodes. In like fashion to evolution of parasitism
among nematodes, we can predict that additional analyses of
parasitic and free-living flatworm genomes will provide deeper
insights into how and when parasitism evolved in the phylum
Platyhelminthes, particularly in comparison to the fresh-water
planarian S. mediterranea, a non-parasitic flatworm for which a draft
genome is available [53]. In addition to evolution of parasitism of
humans and other vertebrate hosts, helminth parasite genome
sequences will also facilitate evolutionary studies on the role of
intermediate hosts/vectors such as the snail in schistosome
infections and the mosquito in filarial infections in this evolution.
Host–Parasite Relationships
Investigations of regulatory networks involved in the embryonic
development, organogenesis, development, and reproduction of
helminths based on newly available genome sequences have
revealed the presence of well-characterized signaling pathways,
including those for Wnt, Notch, Hedgehog, and transforming
growth factor b (TGF-b). These pathways can be recognized in the
B. malayi and schistosome genomes [22,24,25]. These include
endogenous hormones including epidermal growth factor (EGF)-
like and fibroblast growth factors (FGF)-like peptides. Predicted
components of the Ras–Raf–MAPK and TGF-b–SMAD signaling
pathways (including FGF and EGF receptors), for example,
encoded by these genomes, have components sharing high
sequence identity with their mammalian orthologs, implying that
schistosomes or filarial worms, in addition to utilizing their own
pathways, might exploit host growth factors as developmental
signals.
Immune regulation by helminth parasites includes suppression,
diversion, and alteration of the host immune response, resulting in
an anti-inflammatory environment that is favorable to parasite
survival. For example, chronic infections induce key changes in
host immune cell populations including dominance of the T-helper
2 (Th2) cells and selective loss of effector T cell activity, against a
background of regulatory T cells, alternatively activated macro-
phages, and Th2-inducing dendritic cells [54,55]. With advances
in genomics, numerous parasite-derived proteins, including
cytokine homologs, protease inhibitors, and an intriguing set of
novel products, as well as glycoconjugates and small lipid moieties,
have been discovered with known or hypothesized roles in
immune interference [56–61]. These studies suggest that secreted
parasite products interfere with different arms of the immune
system by influencing the cytokine network and signal transduc-
tion pathways or by inhibiting essential enzymes. Using bioinfor-
matics to compare the predicted proteome of B. malayi to proteins
implicated in the immune response (interleukins, chemokines, and
other signaling molecules), potential immune modulators pro-
duced by the filarial have been identified, including genes
encoding the macrophage migration inhibition family of signaling
proteins [62]. Furthermore, the genome of the blood fluke S.
mansoni encodes a large array of paralogues of fucosyl and
xylosyltransferases [25] that are involved in generating novel
glycans at the host–parasite interface and could have an important
role in the subverting the host immune system. A recent
comprehensive review summarizes our current understanding of
the growing number of individual helminth mediators that target
key receptors or pathways in the mammalian immune system [63].
Helminth infection can have a broad impact on the entire
immune system. Infection with trematode and nematode parasites,
for example, correlates with a reduced incidence of atopic,
allergic-type disorders [64]. Thus, helminth infection might
potentially be useful as a novel therapy for allergic or autoimmune
diseases [65]. Recently, worms, eggs, or purified nematode
parasite protein have been used in preclinical and clinical trials
to protect humans from allergy and autoimmunity (reviewed in
[66–70]), including Crohn’s disease and ulcerative colitis [71,72].
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Other studies have shown that substances produced by helminths,
for example Ascaris suum, Nippostrongylus brasiliensis, and Acanthochei-
lonema viteae, can directly interfere with allergic responses or with
development of allergen-specific Th2 responses [73–75]. ES-62, a
molecule secreted by the filarial nematode A. viteae, directly inhibits
the FceRI-induced release of mediators from mast cells, protects
against mast-cell–dependent hypersensitivity in skin and lungs [76]
and inhibits collagen-induced arthritis [77]. Research is underway
to develop molecules that mimic the activity of ES-62 as drugs for
allergic and autoimmune diseases [66]. Other helminth-derived
products have the potential to reduce allergic responses. These
products include schistosomal lysophosphatidylserine (lyso-PS)
[61] and thioredoxin peroxidase from the liver fluke Fasciola
hepatica [78]. These findings demonstrated that helminths produce
products that can interfere with both the development of allergic
responses and the workings of host effector mechanisms.
The ‘‘Dependent’’ Helminth
As a consequence of evolution of an obligatory parasitic
existence, helminth parasites are dependent upon their interme-
diate and definitive hosts for many necessities including nutrients
such as amino acids; filariae are dependent on insect vectors to
transport them to the host. The newly available genome sequences
for schistosomes and B. malayi have confirmed earlier biochemical
studies that had revealed aspects of physiological/ biochemical
dependence of these parasites on the host. For example,
schistosomes cannot synthesize fatty acids de novo, or sterols,
purines, and nine human essential amino acids plus arginine or
tyrosine, and must catabolize complex precursors obtained from
their hosts. Loss or degeneracy of fatty acid, sterol, and purine
synthesis pathways in schistosomes likely relates to the adoption of
a parasitic lifestyle; it is notable that genes encoding all the key
enzymes for both the de novo fatty acid and purine syntheses are
complete in the (free-living) planarian S. mediterranea. To obtain
essential lipid nutrients, the schistosome genome encodes trans-
porters, including apolipoproteins, low-density lipoprotein recep-
tor, scavenger receptor, fatty-acid-binding protein, ATP-binding-
cassette transporters and cholesterol esterase, to exploit fatty acids
and cholesterol from host blood [25,79].
Many species of filarial nematodes are themselves infected by
the endosymbiotic bacterium Wolbachia. The genome sequence of
the Wolbachia species that infects the roundworm nematode B.
malayi (wBm) [80] helped establish which metabolites the
bacterium potentially provides to the nematode (riboflavin, flavine
adenine dinucleotide, heme, and nucleotides, for example) and
which are provided by the nematode to the endobacterium
(notably, amino acids). This type of information has opened up the
exciting possibility that drugs already registered for human use
might inhibit key biochemical pathways in Wolbachia that could
sterilize or kill the adult worms. Although the Wolbachia genome is
even more degenerate than that of the related pathogen Rickettsia,
it has retained more intact metabolic pathways than Rickettsia. This
may be important in its biochemical contribution to host (i.e.,
filarial) viability and fecundity.
The wBm genome encodes many more proteases and
peptidases than Rickettsia, which likely degrade host proteins in
the extracellular environment. Other proteins encoded by wBm
include a common type IV secretion system, as used by some
pathogenic gram-negative bacteria to transfer plasmids and
proteins into surrounding host cells, and an abundance of ankyrin
domain-containing proteins, which might regulate host gene
expression, as suggested for Ehrlichia phagocytophilia AnkA [81], as
well as several proteins predicted to localize on the cell surface.
Ankyrin domain–containing proteins are noteworthy because of
their roles in protein–protein interactions in a variety of cellular
processes. A number of other wBm molecules are of interest as
potential drug targets. For example, glutathione biosynthesis genes
may provide glutathione for the protection of the filaria from
oxidative stress or human immunological effector molecules.
Heme produced from wBm (all five synthesis genes are present)
could be vital to worm embryogenesis, as there is evidence that
molting and reproduction are controlled by ecdysteroid-like
hormones [82], synthesis of which requires heme. Depletion of
Wolbachia might therefore halt production of these hormones and
block molting and/or embryogenesis in B. malayi. Most, if not all,
nematodes, including B. malayi, appear to be unable to synthesize
heme, but must obtain it from extraneous sources, such as the host,
the food supply, or perhaps from endosymbionts.
Challenges for the Future
The filarial and schistosome genome sequences now available
provide the vanguard for assembly of a genome sequence catalog
of the numerous other neglected helminth parasites (Table 1).
Comparative genomics will likely be a dominant approach to
organize, interpret, and utilize the vast amounts of genomic
information anticipated from the genomes of these parasites (e.g.
[83,84]). In terms of sequencing tools, the new generation of
‘‘massively parallel’’ sequencing platforms commercially available
today, (such as the Roche/454 pyrosequencer [85], Illumina/
Solexa [86], and SOLiD [87]) offer of the order of 100- to 1,000-
fold increases in throughput over the Sanger sequencing
technology [88] on capillary electrophoresis instruments. This
rapid change to producing millions of DNA sequence reads in a
short time will have a huge impact on research on NTDs. Each
platform has a specific application: while the Roche/454 is
optimal for in-depth analysis of whole transcriptomes and de novo
sequencing of bacterial and small eukaryotic genomes, the
Illumina and SOLiD systems are highly attractive for resequencing
projects aimed at identifying genetic variants (mutations, inser-
tions, deletions), profiling and discovering noncoding RNAs
(ncRNAs), and studying epigenetic modifications of histones and
DNA. With the increased read length and improved error rate of
massively parallel pyrosequencing technology, de novo sequencing
of helminth genomes has become possible at a fraction of earlier
costs. In the next five years, projects at the Washington
University’s Genome Center (http://www.genome.gov/
10002154) and the Wellcome Trust Sanger Institute (http://
www.sanger.ac.uk/Projects/Helminths/) should increase the
available sequence data on human helminths and their close
relatives by an order of magnitude, adding more than 20 draft
genomes to those listed in Table 1.
Once these reference genomes become available, sequencing of
clinical isolates is expected to accelerate. Sequencing of the clinical
strains and strain-to-reference comparisons can be performed
using platforms such as Illumina/Solexa and SOLiD to investigate
genome-wide polymorphism and provide a comprehensive picture
of natural helminth genome variation. These approaches should
also be valuable for exploring genetic changes involved in
resistance to anti-worm drugs and understanding the potential
mechanisms of drug resistance in human parasites, and can be
expected to facilitate development of genetic markers to monitor
and manage any future appearance and spread of drug resistance.
These phenomena are of tremendous importance, particularly
since some major neglected helminth diseases are being targeted in
mass drug treatment campaigns [89]. In addition, the new
generation of sequencing technologies has also provided unprec-
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edented opportunities for high-throughput functional genomic
research (reviewed in [90]) that awaits application to helminth
research.
Although some details of immunomodulation by helminth
components have been characterized, we are just beginning to
understand how these parasite products act on immune responses
and to assemble fragmentary information on individual compo-
nents into a comprehensive picture. Comparisons of helminth
molecules with orthologues/paralogues from free-living relatives
will strengthen efforts to decipher the strategies adopted by
helminth parasites to evade and subvert their host immune
responses. This information will be exploitable for development of
drugs and vaccines against the parasites and potentially also novel
therapeutic biologics for use in humans. Future studies might
determine whether helminth proteins with unknown function
might be the source for the intriguing regulatory effects helminth
infections have on the host immune response.
Treatment for helminthic infections, responsible for hundreds of
thousands of deaths each year, depends almost exclusively on just
two or three drugs: praziquantel, the benzimidazoles, and
ivermectin. Vaccines and new drugs are needed, certainly because
drug resistance in human helminth parasites such as schistosomes,
whipworms, and filariae, to these compounds would present a
major problem for current treatment and control strategies.
Pharmacogenomics with the new helminth genomes represents a
practicable route forward toward new drugs. For example,
chemogenomics screening of the genome sequence of S. mansoni
identified .20 parasite proteins for which potential drugs are
available approved for other human ailments [25], and indeed for
which, in the case of the schistosome thioredoxin glutathione
reductase, auranofin (an anti-arthritis medication) was shown
recently to exhibit potent anti-schistosomal activity [91]. Finally,
the vast new sequence information will undoubtedly allow revision
of our understanding of the host–parasite relationship, its
evolution, vector–pathogen and helminth–symbiont interactions,
unique aspects of cell biology and biochemistry, phylogenetic
relationships, intervention targets, research approaches (e.g. [92]),
and so forth.
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